Hepatic TRβ signalling is impaired in human and murine NASH, and vice versa, elevating hepatic TH action improves non-alcoholic hepatosteatosis (NASH). Using human liver biopsies, NASH mouse models and iPSC-derived hepatocytes, we aim to identify the mechanisms that cause reduced TRβ expression in NASH, testing the hypothesis that this is mediated by epigenetic mechanisms involving miRNA and DNA methylation. Finally, we hypothesise that improving hepatic TRβ signalling in NASH will improve current treatment strategies.
|Effective start/end date||01.01.20 → …|
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):
Research Areas and Centers
- Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)
DFG Research Classification Scheme
- 205-17 Endocrinology, Diabetology
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.